GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kineta Inc (STU:J75) » Definitions » EV-to-EBIT

Kineta (STU:J75) EV-to-EBIT : -0.20 (As of Jul. 16, 2025)


View and export this data going back to 2017. Start your Free Trial

What is Kineta EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Kineta's Enterprise Value is €3.69 Mil. Kineta's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was €-18.93 Mil. Therefore, Kineta's EV-to-EBIT for today is -0.20.

The historical rank and industry rank for Kineta's EV-to-EBIT or its related term are showing as below:

STU:J75's EV-to-EBIT is not ranked *
in the Biotechnology industry.
Industry Median: 11.645
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Kineta's Enterprise Value for the quarter that ended in Jun. 2024 was €5.95 Mil. Kineta's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was €-18.93 Mil. Kineta's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -317.92%.


Kineta EV-to-EBIT Historical Data

The historical data trend for Kineta's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kineta EV-to-EBIT Chart

Kineta Annual Data
Trend Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
- - -0.86 -3.04

Kineta Quarterly Data
Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.35 -0.61 -3.04 -0.31 -0.32

Competitive Comparison of Kineta's EV-to-EBIT

For the Biotechnology subindustry, Kineta's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kineta's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kineta's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Kineta's EV-to-EBIT falls into.


;
;

Kineta EV-to-EBIT Calculation

Kineta's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=3.694/-18.927
=-0.20

Kineta's current Enterprise Value is €3.69 Mil.
Kineta's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-18.93 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kineta  (STU:J75) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Kineta's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2024 ) =EBIT / Enterprise Value (Q: Jun. 2024 )
=-18.927/5.953344
=-317.92 %

Kineta's Enterprise Value for the quarter that ended in Jun. 2024 was €5.95 Mil.
Kineta's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-18.93 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Kineta EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Kineta's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Kineta Business Description

Traded in Other Exchanges
Address
7683 SE 27th Street, Suite 481, Mercer Island, WA, USA, 98040
Kineta Inc is a clinical stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients' lives. The company has leveraged its expertise in innate immunity and is focused on discovering and developing potentially differentiated immunotherapies that address the mechanisms of cancer immune resistance.

Kineta Headlines

No Headlines